These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 11698470

  • 21. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA, Ward B, Schatzle JD, Bennett M.
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [Abstract] [Full Text] [Related]

  • 22. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection.
    Yoshimoto T, Takahama Y, Wang CR, Yoneto T, Waki S, Nariuchi H.
    J Immunol; 1998 Jun 01; 160(11):5500-5. PubMed ID: 9605153
    [Abstract] [Full Text] [Related]

  • 23. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
    Hazeki K, Masuda N, Funami K, Sukenobu N, Matsumoto M, Akira S, Takeda K, Seya T, Hazeki O.
    Eur J Immunol; 2003 Mar 01; 33(3):740-7. PubMed ID: 12616494
    [Abstract] [Full Text] [Related]

  • 24. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.
    Int Immunol; 2007 Mar 01; 19(3):311-20. PubMed ID: 17289654
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
    Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T, Akira S.
    Int Immunol; 2002 Jul 01; 14(7):695-700. PubMed ID: 12096028
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.
    Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M.
    J Immunol; 2002 Feb 01; 168(3):1435-40. PubMed ID: 11801686
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.
    Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF.
    Science; 2005 Aug 26; 309(5739):1380-4. PubMed ID: 16123302
    [Abstract] [Full Text] [Related]

  • 31. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
    Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Mühlradt PF, Akira S.
    J Immunol; 2000 Jan 15; 164(2):554-7. PubMed ID: 10623793
    [Abstract] [Full Text] [Related]

  • 32. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88.
    Eisenbarth SC, Zhadkevich A, Ranney P, Herrick CA, Bottomly K.
    J Immunol; 2004 Apr 01; 172(7):4527-34. PubMed ID: 15034070
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.
    J Immunol; 2001 Feb 01; 166(3):1590-600. PubMed ID: 11160200
    [Abstract] [Full Text] [Related]

  • 34. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis.
    Singh JC, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, Lodge JP, Felsburg PJ, Carding SR.
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar 01; 288(3):G514-24. PubMed ID: 15499080
    [Abstract] [Full Text] [Related]

  • 35. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner.
    Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, Ploegh H.
    J Immunol; 2003 Oct 15; 171(8):4081-8. PubMed ID: 14530329
    [Abstract] [Full Text] [Related]

  • 36. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
    Akira S, Hoshino K.
    J Infect Dis; 2003 Jun 15; 187 Suppl 2():S356-63. PubMed ID: 12792852
    [Abstract] [Full Text] [Related]

  • 37. Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.
    Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K.
    J Immunol; 1998 Jan 01; 160(1):16-9. PubMed ID: 9551949
    [Abstract] [Full Text] [Related]

  • 38. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
    Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D.
    Infect Immun; 2001 Apr 01; 69(4):2270-6. PubMed ID: 11254583
    [Abstract] [Full Text] [Related]

  • 39. Protective T cell response against intracellular pathogens in the absence of Toll-like receptor signaling via myeloid differentiation factor 88.
    Kursar M, Mittrücker HW, Koch M, Köhler A, Herma M, Kaufmann SH.
    Int Immunol; 2004 Mar 01; 16(3):415-21. PubMed ID: 14978015
    [Abstract] [Full Text] [Related]

  • 40. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
    Singh RP, Kashiwamura S, Rao P, Okamura H, Mukherjee A, Chauhan VS.
    J Immunol; 2002 May 01; 168(9):4674-81. PubMed ID: 11971017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.